Bill117th CongressFiled Aug 2, 2022Health
H.R. 8641
Orphan Drug COVID–19 Mitigation Act of 2022
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Aug 2, 2022)
Orphan Drug COVID-19 Mitigation Act of 2022
This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.
What just happenedAug 2, 2022
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Gottheimer, Josh [D-NJ-5](D-NJ)Sponsor
3 cosponsors2 D1 R
3cosponsors1committees3actions
- Introduced in HouseAug 2, 2022
- Aug 2, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Aug 2, 2022IntroReferralIntro-H
Introduced in House
- Aug 2, 2022IntroReferral1000
Introduced in House